Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Standardized protocol to identify high-risk patients undergoing therapeutic apheresis procedures.

Lu Q, Nedelcu E, Ziman A, Bumerts P, Fernando L, Schiller G.

J Clin Apher. 2008;23(3):111-5. doi: 10.1002/jca.20167.

PMID:
18521857
2.

Moderate and severe adverse events associated with apheresis donations: incidences and risk factors.

Yuan S, Ziman A, Smeltzer B, Lu Q, Goldfinger D.

Transfusion. 2010 Feb;50(2):478-86. doi: 10.1111/j.1537-2995.2009.02443.x. Epub 2009 Oct 15. Review.

PMID:
19843285
3.

Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures.

Kiprov DD, Golden P, Rohe R, Smith S, Hofmann J, Hunnicutt J.

J Clin Apher. 2001;16(3):130-3.

PMID:
11746539
4.

Risk factors for acute, moderate to severe donor reactions associated with multicomponent apheresis collections.

Yuan S, Gornbein J, Smeltzer B, Ziman AF, Lu Q, Goldfinger D.

Transfusion. 2008 Jun;48(6):1213-9. doi: 10.1111/j.1537-2995.2008.01674.x. Epub 2008 Mar 13.

PMID:
18346014
5.

Complications of apheresis in children.

Michon B, Moghrabi A, Winikoff R, Barrette S, Bernstein ML, Champagne J, David M, Duval M, Hume HA, Robitaille N, Bélisle A, Champagne MA.

Transfusion. 2007 Oct;47(10):1837-42.

PMID:
17880609
6.

The Canadian apheresis registry.

Rock G, Clark B, Sutton D; CAG; CAAN.

Transfus Apher Sci. 2003 Oct;29(2):167-77.

PMID:
12941357
7.

Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks.

Stefanutti C, Lanti A, Di Giacomo S, Mareri M, De Lorenzo F, Landolfo A, Isacchi G.

Transfus Apher Sci. 2004 Aug;31(1):3-10.

PMID:
15294188
8.

The Italian Registry of Pediatric Therapeutic Apheresis: a report on activity during 2005.

De Silvestro G, Tison T, Vicarioto M, Bagatella P, Stefanutti C, Marson P.

J Clin Apher. 2009;24(1):1-5. doi: 10.1002/jca.20184.

PMID:
19073013
9.

Complications of therapeutic apheresis in children.

Kara A, Turgut S, Cağlı A, Sahin F, Oran E, Tunç B.

Transfus Apher Sci. 2013 Jun;48(3):375-6. doi: 10.1016/j.transci.2013.04.020. Epub 2013 May 16.

PMID:
23685078
10.

Scope and application of therapeutic apheresis: Experience from a tertiary care hospital in North India.

Sharma RR, Saluja K, Jain A, Dhawan HK, Thakral B, Marwaha N.

Transfus Apher Sci. 2011 Dec;45(3):239-45. doi: 10.1016/j.transci.2011.09.002. Epub 2011 Oct 28.

PMID:
22036963
11.

Therapeutic apheresis: treatment in search of a disease.

[No authors listed]

J Health Care Technol. 1985 Spring;1(4):279-98.

PMID:
10274623
12.

Guidelines for apheresis personnel--an overview.

Cole B.

J Clin Apher. 1985;2(4):311-4.

PMID:
4066632
13.

Therapeutic apheresis in critically ill patients.

Sanford KW, Balogun RA.

J Clin Apher. 2011;26(5):249-51. doi: 10.1002/jca.20304. Epub 2011 Aug 10. Review.

PMID:
21834079
14.

A protocolized approach to identify and manage hyperglycemia in a pediatric critical care unit.

Preissig CM, Hansen I, Roerig PL, Rigby MR.

Pediatr Crit Care Med. 2008 Nov;9(6):581-8. doi: 10.1097/PCC.0b013e31818d36cb.

PMID:
18838924
15.

Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications.

Linenberger ML, Price TH.

J Intensive Care Med. 2005 Mar-Apr;20(2):88-103. Review.

PMID:
15855221
16.

Physician coverage of therapeutic apheresis.

Woll JE.

J Clin Apher. 1995;10(4):183-7.

PMID:
8770710
17.

Therapeutic apheresis: a review of complications and recommendations for prevention and management.

Mokrzycki MH, Balogun RA.

J Clin Apher. 2011;26(5):243-8. doi: 10.1002/jca.20303. Epub 2011 Sep 5. Review.

PMID:
21898573
18.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
19.

Therapeutic apheresis in Taiwan.

Yeh JH, Chiu HC; Therapeutic Apheresis Registry Group in Taiwan.

Ther Apher. 2001 Dec;5(6):513-6.

PMID:
11800091
20.

Therapeutic apheresis in Sweden: update of epidemiology and adverse events.

Norda R, Stegmayr BG; Swedish Apheresis Group.

Transfus Apher Sci. 2003 Oct;29(2):159-66.

PMID:
12941356

Supplemental Content

Support Center